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Introduction
Active suppression mediated by regulatory cells is important for the maintenance of transplant tolerance. We have previously shown that pretreatment with the intratracheal delivery (ITD) of alloantigen induced hyporesponsiveness to fully mismatched cardiac allografts and induced donor-specific regulatory cells including CD4 + CD25 + regulatory T cells (Tregs) in the spleen within 7 days [1] [2] [3] . Various costimulatory pathways [4] [5] [6] and IL-10 are essential [7] for the generation of regulatory cells after ITD. Moreover, we showed that intratracheally delivered donor splenocytes were not detected in paratracheal lymph nodes (pLN) or spleen implying these delivered cells were immediately digested and processed without migrating out of the lung [1, 3] . In addition, the depletion of alveolar macrophages, which regulate the reaction against exogenous antigen, impaired the induction of Tregs leading to the abrogation of graft survival prolongation [3] . However, the exact mechanism of Tregs induction in the spleen, especially the initial events in the respiratory system after ITD, remains unknown.
Dendritic cells (DCs), specialized antigen-presenting cells, are integral for the generation of Tregs [8] . Thus, DCs with tolerogenic potential might be a candidate for the generation of Tregs, which protect allografts in our ITD model.
Objectives
In this study, we demonstrated that ITD-treated DCs induce fully mismatched cardiac allograft survival, that regulatory DCs induced by ITD treatment secreted high amounts of IL-10 and induced Tregs in vivo, and that CD8α + DCs were the major subpopulation of the regulatory DCs.
Materials and Methods

Mice
Inbred male C57BL/10 (H-2 b , donors) and CBA (H-2 k , recipients) mice at 8-12 weeks of age were purchased from Sankyo Ltd. (Tokyo, Japan), housed in conventional facilities in the Biomedical Service Unit of Teikyo University, and used in accordance with protocols for animal experiments approved by the Animal Care and Use Committee of Teikyo University.
Reagents
Lipopolysaccharide (LPS) was purchased from Sigma Chemical Co. (St. Louis, MO). IL-10 recombinant standard, capture monoclonal antibody (mAb) (JES5-2A5), and 8 8 detection mAb (JES5-16E3) for enzyme-linked immunosorbent assays (ELISA) were purchased from BD Biosciences (San Jose, CA). The capture and detection mAbs for IL-12 p40 (C15.6 and C17.8, respectively) and recombinant IL-12 p40 were from PeproTech (London, UK). For flow cytometry, fluorochrome-conjugated mAbs for CD11c (HL3), CD8α (53-6.7), CD80 (16-10A1), CD86 (GL1), and CBA MHC class II I-E k (17-3-3) were purchased from BD Biosciences; F4/80 (BM8) and CD103 (2E7) were purchased from BioLegend (San Diego, CA); CD205 (DEC205) was purchased from Miltenyi Biotec (Teterow, Germany); CD68 (FA-11) was purchased from Bio-Rad (Oxford, UK); and CD207 (eBioL31) was purchased from eBioscience (San Diego, CA).
Intratracheal Delivery of Alloantigen
C57BL/10 splenocytes were used as alloantigens and ITD was performed as previously described [1] . In brief, CBA mice were placed under general anesthesia, the trachea was exposed by dissection of the overlying muscles, and 1×10 7 C57BL/10 splenocytes in 100 µl phosphate-buffered saline (PBS) were injected directly into the trachea through a 30 G needle ( Fig. 1A ).
Heart Transplantation
CBA mice were given ITD of donor splenocytes and 7 days later, the CBA mice 9 9 underwent transplantation of fully vascularized heterotopic heart grafts from C57BL/10 mice with microsurgical techniques [9] . Graft rejection was defined as complete cessation of heartbeat and confirmed by direct visualization of the graft as well as its histology.
Adoptive Transfer Studies
Adoptive transfer studies were conducted to determine whether regulatory cells were generated after ITD and which subsets were involved in the regulatory function in vivo. As shown in Figure 1B , splenocytes were obtained from CBA mice that had been given ITD of C57BL/10 splenocytes (1×10 7 cells) 7 days previously. Naïve CBA mice intravenously injected with whole splenocytes (5×10 7 cells in 100 µl of PBS) from ITD-treated mice then received the transplantation of C57BL/10 hearts on the same day. In some groups, CD11c + DCs, CD8α + CD11c + or CD8α -CD11c + DCs were isolated from naïve or ITD-treated (7 days previously) CBA mice spleens by AUTOMACS (Miltenyi Biotec Inc., Auburn, CA) and the cells were transferred into naïve CBA recipients (1×10 6 cells per mouse) that received cardiac transplantation.
In addition, to determine the function of splenic DCs to induce Tregs in vivo, a sequential adoptive transfer study was performed (Fig. 1C ). In an additional study, splenic DCs (1×10 6 cells) from ITD-treated (7 days previously) CBA mice were transferred into 10 10 naïve CBA recipients (primary recipients) with C57BL/10 heart transplantation. Fourteen days after the transplant with adoptive DC transfer, splenic CD4 + T cells (2×10 7 cells) were isolated from the DC-transferred CBA recipients with cardiac allografts and adoptively transferred into another group of naive CBA recipients (secondary recipients) that received transplantation of C57BL/10 hearts.
Isolation of Splenic DCs
DCs were isolated from the mouse spleen of naïve, ITD-treated, or heart transplant recipients. Briefly, spleens were digested with collagenase D (1 mg/mL; Boehringer Mannheim, Roche, Germany), and mononuclear cells were isolated by Histopaque 1083 (Sigma-Aldrich Inc., Saint Louis, MI) gradient centrifugation. Then, CD11c + cells were isolated using AUTOMACS and a mouse pan Dendritic Cell Isolation Kit (Miltenyi Biotec Inc.). Purity was >95% as determined by microscopy. Splenic CD8α + DCs and CD8α -DCs were also isolated by AUTOMACS and a mouse CD8α + Dendritic Cell Isolation Kit (Miltenyi Biotec Inc.).
Flow Cytometry
All staining reactions were performed at 4°C. First, cells were incubated with Fcγ receptor II/III mAb (2.4G2; BD Biosciences) to reduce nonspecific binding. To detect 11 11 splenic DCs, single cell suspensions were stained with fluorochrome-labeled anti-CD11c and anti-CD8α mAbs. CD8α + and CD8αsplenic DCs were further stained with anti-DEC205, F4/80, CD68, CD11b, CD103, CD207 and MHC II (I-E k ) mAbs [10] .
Fluorescence was analyzed by FACSCalibur and FACSCanto II (BD Bioscience, San Jose, CA).
Cytokine Assays
To determine the function of DCs to secrete cytokines in vitro, splenic CD11c + DCs isolated by AUTOMACS from naïve CBA or ITD-treated CBA mice were stimulated by LPS and concentrations of IL-10 and IL-12 in the culture media were assessed by ELISA.
For stimulation, splenic DCs were seeded at 2×10 5 cells/well in 96-well culture plates and stimulated with LPS (1 or 10 µg/ml) or unstimulated for 24 hours [11] . After stimulation, cell-free supernatants were collected and analyzed by ELISA as described previously [12] .
Statistical Analysis
Survival times for cardiac allografts in different groups of mice were compared by the log-rank test. The results of ELISA and flow cytometric studies were compared by unpaired Student's t-test or analysis of variance (ANOVA) with a post ad hoc Tukey-Kramer method.
Analysis was performed using GraphPad Prism ver. 6.0 (GraphPad Software Inc., La Jolla, 12 12 CA). Values of p < 0.05 were considered statistically significant differences between two groups.
Results
Intratracheal Delivery of Alloantigen Prolongs Allograft Survival and Induces
Regulatory Cells in Recipients
As we previously reported [1] , the ITD of C57BL/10 splenocytes into CBA recipients 7 days before transplantation significantly prolonged the survival of cardiac allografts (MST, 67 days) compared with untreated (naïve) recipients (MST, 8 days, p<0.0001, Fig. 2A ). The ITD of syngeneic (CBA) splenocytes did not prolong C57BL/10 cardiac allograft survival in CBA recipients (MST, 8 days, Fig. 2A ). The optimal number of splenocytes for ITD treatment and the optimal time for cardiac transplant after ITD treatment were initially determined based on additional experiments. First, we administered various numbers of splenocytes to recipients for ITD treatment before cardiac transplantation. We divided mice into 4 groups of cardiac transplant recipients with ITD pretreatment of 1×10 5 , 1×10 6 , 1×10 7 , or 1×10 8 splenocytes 7 days before transplant. Their MSTs were 12, 36, 84, and 78 days, respectively. These data suggest that the effect on prolongation of allograft survival induced 13 13 by ITD treatment is dose (cell number)-dependent and that the optimal cell number for ITD treatment is 1×10 7 . Then, we divided mice into 5 groups to determine the optimal time after ITD treatment for cardiac transplantation. We performed cardiac transplantation at 1, 3, 7, 14, and 28 days after ITD treatment. MSTs in these groups were 9, 11, 84, 23, and 11 days, respectively, suggesting that the optimal time for cardiac transplantation is 7 days after ITD treatment.
To determine the presence of regulatory cells after ITD, we adoptively transferred splenocytes into naïve CBA recipients that received cardiac transplantation ( Fig.   1B ). As we reported previously [6] , the adoptive transfer of splenocytes into naïve CBA recipients from CBA mice treated with the ITD of C57BL/10 splenocytes 7 days previously, significantly prolonged the survival of C57BL/10 cardiac allografts (MST, 72.5 days). In contrast, CBA recipients adoptively transferred splenocytes from naive CBA mice rejected C57BL/10 hearts (MST, 9 days, p<0.0001 vs. adoptive transfer of ITD-treated splenocytes, Fig. 2B ). These results suggested that the ITD of allogeneic splenocytes induced regulatory cells in recipient spleens. The optimal number of splenocytes and optimal timing for the adoptive transfer after ITD pretreatment were also determined based on additional experiments using recipient groups with various timings for the adoptive transfer of 14 14 splenocytes from ITD-treated mice. In the experiment, 5×10 7 splenocytes were isolated from ITD-treated mice at 1, 3, 7, 14, and 28 days after ITD. The splenocytes were transferred into naïve CBA mice that underwent cardiac transplant at the same time as the adoptive transfer. Graft survival was markedly prolonged when splenocytes were harvested for transfer 7 days after ITD (MST, 68 days), while graft survival was modestly or barely prolonged with when harvested at 1, 3, 14, and 28 days after ITD treatment (MSTs, 12, 24, 28 and 14 days, respectively). These results indicate that 7 days is the optimal time for the generation of regulatory cells after the intratracheal delivery of splenocytes. Furthermore, we assessed the optimal dose for adoptive transfer after ITD of donor splenocytes. Naive CBA mice were adoptively transferred 5×10 5 , 5×10 6 , or 5×10 7 splenocytes, from CBA mice pretreated 7 days earlier with ITD of 1×10 7 C57BL/10 splenocytes. Immediately after the adoptive transfer, CBA mice underwent transplantation of C57BL/10 hearts. The CBA recipients receiving the adoptive transfer of 5×10 6 splenocytes had moderate increases in the survival of C57BL/10 grafts (MST, 32 days), compared with recipients adoptively transferred 5×10 7 splenocytes from ITD-treated mice (MST, 68 days). When CBA recipients were adoptively transferred 5×10 5 splenocytes from CBA mice pretreated 7 days 15 15 earlier with ITD, C57BL/10 cardiac grafts were rejected acutely (MST, 12 days). Thus, 5×10 7 splenocytes is the optimal dose for adoptive transfer in our ITD model.
We previously showed that regulatory cells induced by ITD included CD4 + CD25 + Tregs [3] . Moreover, the results from our preliminary study of the adoptive transfer of splenic DCs suggested the possible existence of a DC population in the regulatory cells [3] . To confirm our preliminary results, we isolated CD11c + DCs from the spleens of ITD-treated or untreated (naïve) mice by AUTOMACS and then transferred them into CBA recipients (Fig. 1B) . Cardiac graft survival was significantly prolonged compared with the secondary recipients transferred with splenic DCs from naïve mice (MST, 85 and 9 days, respectively, p<0.01, Fig. 2C ).
These results indicated that one population of regulatory cells induced by ITD is CD11c + cells (i.e. regulatory DCs).
Regulatory DCs induced by ITD induce Tregs in vivo
To determine the regulatory function of splenic DCs from ITD-treated mice (regulatory DCs induced by ITD) to prolong allograft survival, we performed a sequential adoptive transfer study. As shown in Figure 1C , C57BL/10 splenocytes were intratracheally delivered into naive CBA mice. Seven days later, splenic DCs from ITD-treated mice were 16 16 adoptively transferred into primary CBA recipients that subsequently received C57BL/10 hearts. Then, 14 days later, splenic CD4 + T cells from primary recipients were transferred into naïve CBA recipients (secondary recipients) that received a C57BL/10 cardiac allograft immediately. Secondary recipients had a markedly prolonged allograft survival compared with recipients transferred with splenic CD4 + T cells from naïve mice (MST, >100 and 12 days, respectively, p<0.01, Fig. 3A) . These results suggested that the adoptive transfer of splenic DCs from ITD-treated mice induced CD4 + Tregs in secondary recipients as well as prolonging graft survival.
To determine the characteristics of regulatory DCs in vitro, splenic DCs from ITD-treated mice or naïve CBA mice were incubated with LPS (1 µg/ml or 10 µg/ml) or without LPS. Naïve DCs produced a small amount of IL-10 either with or without LPS stimulation (untreated, 18±4 pg/ml; 1 µg/ml of LPS, 25±3 pg/ml; 10 µg/ml of LPS, 22±5 pg/ml, respectively, Fig. 3B ). In contrast, DCs from ITD-treated mice produced significantly higher amounts of IL-10 compared with naïve splenic DCs and LPS stimulation upregulated IL-10 production in a dose-dependent manner (untreated, 152±35 pg/ml; 1 µg/ml of LPS, 524±87 pg/ml; 10 µg/ml of LPS, 2189±516 pg/ml, respectively, p<0.05 compared with naive counterparts, Fig. 3B ). Naïve DCs produced a small amount of IL-12 without stimulation and LPS upregulated IL-12 in a dose-dependent manner (untreated, 118.7±17.3 ng/ml; 1 µg/ml of LPS, 2309.4±265.2 ng/ml; 10 µg/ml of LPS, 3587.9±953.1 ng/ml, respectively, Fig. 3C ). In contrast, ITD-treated DCs did not produce IL-12 when unstimulated or stimulated with LPS (untreated, 86±13.9 ng/ml; 1 µg/ml LPS, 261.8±98.7 ng/ml; 10 µg/ml LPS, 168.3±72.6 ng/ml, respectively, Fig. 3C ). These results indicated that ITD-treated DCs have the potential to produce more IL-10 compared with naïve DCs or unstimulated ITD-DCs.
Regulatory DCs from ITD-treated mice are positive for CD8α
To determine which subpopulation of ITD-treated splenic DCs has regulatory function, splenic CD8α + or CD8α -DCs from ITD-treated mice were adoptively transferred into naïve CBA recipients that received C57BL/10 hearts immediately. CD8α + DCs significantly prolonged allograft survival compared with CD8α -DCs (MST, 79 and 9 days, respectively, p<0.0001, Fig. 4A ), suggesting that a major population of regulatory DCs are CD8α + CD11c + .
Flow cytometric analysis showed that the frequency of CD8α + DCs was slightly but significantly higher in ITD-treated DCs in the spleen compared with naïve DCs (ITD-DC, 28.7±4.4%; naïve DCs, 19.7±1.7%, respectively, Fig. 4B, p<0.05) . To determine their surface molecule expression, CD8α + or CD8α -DCs from ITD-treated mice were analyzed for the expression of CD207 (Langerin), CD103 (αE-integrin), CD205 (DEC205), CD80, and CD86 by flow cytometry. In ITD-treated mice, CD8α + DCs showed a higher expression of CD80, CD86, CD103, and CD205 compared with CD8α -DCs (Fig. 4C) . 19 19 
Discussion
In the current study, we demonstrated that the administration of donor antigen (i.e. donor splenocytes in this study) via the trachea induced the prolongation of fully allogeneic graft survival and generated both CD4 + Tregs and DCs with regulatory function in a murine cardiac transplantation model. Our data also suggested that the major subset of regulatory DCs that induced CD4 + Tregs was CD8α + . We previously reported that IL-10 was necessary for inducing regulatory cells by the ITD of donor cells [7] . In the current experiments, ITD-treated DCs upregulated IL-10 production upon stimulation. Taken together, this suggests that CD8α + regulatory DCs are responsible for the IL-10-mediated induction of Tregs in ITD-treated mice.
Although intratracheal delivery seems an unusual route of administration, the induction of tolerance and regulatory cells by means of the respiratory mucosa has been described in previous studies of autoimmune and allergic diseases [13, 14] . Staines et al. demonstrated that the nasal inhalation of type II collagen-specific peptides reduced the mean disease severity in a rat collagen-induced arthritis model [13] . The presentation of soluble innocuous antigens to the respiratory and intestinal immune systems constantly induces antigen-specific unresponsiveness termed mucosal tolerance. Because intratracheal 20 20 administration was superior to the intravenous administration of donor splenocytes in terms of prolonging allograft survival (MST, 81 and 13 days, respectively), the route of administration has a critical role in defining the fate of allografts [15] .
DCs are specialized antigen-presenting cells that have a dual role in inducing adaptive immune responses that eliminate harmful antigens and inducing immunological tolerance to innocuous antigens [16, 17] . At steady state, DCs are generally immature and are poorly immunogenic because they express only modest levels of MHC molecules and little or no co-stimulatory molecules and proinflammatory cytokines, resulting in the generation of anergic T cells and Tregs [18] .
According to a review by Shortman [19] , CD8α + DCs represent around 20% of splenic DCs. It was also reported that CD8α + DCs in peripheral lymphoid tissues are involved in preventing self-reactive responses [20] . Although splenic CD8α + DCs have a similar expression of co-stimulatory molecules with splenic CD8α -DCs, they induce less proliferation of both CD4 + and CD8 + T cells compared with splenic CD8α -DCs [19, [21] [22] [23] [24] .
Splenic CD8α + DCs are generally at steady state and do not produce sufficient cytokines for the sustained proliferation of T cells, resulting in their death by cytokine deprivation [21] . Yamazaki et al. also showed that splenic CD8α + CD205 + DCs are more effective at 21 21 inducing Foxp3 + Tregs compared with splenic CD8α -DCs both in vitro and in vivo [25] .
Consistent with their data, CD8α + regulatory DCs in our model also expressed CD205. In addition, it was shown that splenic DCs pretreated with ITD produced low levels of IL-12 and high levels of the regulatory cytokine, IL-10, compared with naïve splenic DCs. Their cytokine profile may lead to reduced T cell alloimmune responses and the induction of Tregs.
CD103, the α E integrin subunit, pairs with β 7 to generate a functional integrin that binds to E-cadherin [26] , and this interaction enables human and mouse intestinal leukocytes to adhere to epithelial cells [27] . In the intestine, CD103 + DCs among other intestinal DCs are the critical DC subset for the induction of Tregs [28] . In the spleen, CD8α + DCs are positive for CD103 and CD205 and are crucial for the induction of allogeneic Tregs [29] . Qiu et al. also reported that the depletion of CD8α + CD103 + DCs in the spleen impaired tolerance induction to self-antigens [30] . Consistent with their results, it is likely that the major population of splenic regulatory DCs after ITD treatment is CD8α + . Furthermore, CD103 might be another marker for regulatory DCs in our model.
In conclusion, the data presented showed that ITD treatment prolonged the survival of MHC-mismatched cardiac allografts and induced regulatory DCs. We found that regulatory 22 22 DCs induced by ITD treatment secreted high amounts of IL-10, induced Tregs in vivo, and that CD8α + DCs were the major subpopulation of the regulatory DCs. We previously reported that the intratracheal administration of donor-MHC class I complex-derived peptide corresponding to the complementarity-determining region also prolonged allograft survival in mice [31] . These results suggest that both donor splenocytes and single MHC class I K b peptide was sufficient as the door antigen for ITD pretreatment to induce the prolongation of allograft survival [31, 32] . Therefore, in patients undergoing transplantation, especially in the setting of living donor transplant in which pretreatment is possible, intratracheal delivery would be as easy to use as the oral route to induce donor-specific hyporesponsiveness. When a suitable HLA peptide is identified, the hyporesponsiveness and generation of regulatory cells induced by intratracheal delivery should be applicable to clinical transplantation. Thus, our findings may have significant implications for designing novel strategies for immunomodulatory treatments in transplantation. In clinical transplantation, the development of donor-specific regulatory cells has an advantage of being physiologic without inducing pan-immune suppression leading to infectious diseases.
Several types of regulatory cells produced endogenously by the immune system might be applicable to the clinic to establish hyporesponsiveness or tolerance to alloantigens. 23 23 However, the precise mechanisms of the generation of regulatory cells remain unclear and require additional investigation.
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